Silver Book Fact

Slowing the Progress of Parkinson’s Disease Would Save Money

Fact image

Johnson S, Diener M, Kaltenboeck A, Birnbaum H, et al. An Economic Model of Parkinson’s Disease: Implications for slowing progression in the United States. Mov Disorders. 2013; 28(3). https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.25328

Reference

Title
An Economic Model of Parkinson’s Disease: Implications for slowing progression in the United States
Publication
Mov Disorders
Publication Date
2013
Authors
Johnson S, Diener M, Kaltenboeck A, Birnbaum H, et al.
Volume & Issue
Volume 28, Issue 3
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • The U.S. Food and Drug Administration has approved 5 drugs that have proven to temporarily slow the worsening of Alzheimer’s disease symptoms for an average of 6 – 12 months…  
  • An Alzheimer’s disease research study showed that billions of dollars could be saved if physicians could intervene before someone becomes symptomatic. This positive net savings occurred with both drug treatment…  
  • An Alzheimer’s disease treatment breakthrough that slowed its progression and began to show its effects in 2015, would reduce the Medicare costs for people with the disease by $20 billion…  
  • Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years were introduced in 2015, by 2050 the total reduction in cost of care for people…